A natomic limitations often associated with the posterior maxilla are a flat palatal vault, deficient alveolar height, inadequate posterior alveolus, increased pneumatization of the maxillary sinus, and close approximation of the sinus to crestal bone. Maxillary bone, primarily medullary and trabecular, has less quantity and osseous density than the premaxilla or mandible. Adjacent cortices of compact bone are generally very thin, providing minimal strength.
The maxillary sinus is of particular concern when implant treatment is considered for posteriorly edentulous cases because pneumatization of the sinuses frequently minimizes or completely eliminates vertical bone availability for implants. If there is sufficient alveolar bone height and only partial pneumatization of the sinus, bone grafting and implant placement can be performed simultaneously. The implant can be placed through the crestal bone into the graft material provided there is at least 5 mm of alveolus present to stabilize the implant during the healing period.
Several techniques, including bone grafting the maxillary anterior floor to increase the alveolar height and reduce the size of the sinus, can help overcome a lack of alveolar bone height, via lateral or crestal approaches. Many clinicians believe that more traditional sinus lift procedures, such as a lateral approach, should be used instead of subantral augmentation if the alveolar bone height is to be raised more than 3 mm, although surface-enhanced dental implants can often compensate for minimal bone height in the augmented site. 1, 2 Patients undergoing a sinus lift procedure should have a pathology-free sinus, including no chronic sinusitis. Smoking and uncontrolled periodontal disease must be considered as well; diagnostic wax-ups as well as surgical templates can be used to ensure proper implant placement. Radiographs (periapical and/or panoramic) and computerized tomography can ensure that a minimum of bone height exists between the alveolar crest and the sinus floor.
PLATELET-RICH PLASMA AND ORAL BONE REGENERATION
Because of factors involving its availability and cost, platelet-rich plasma (PRP) has become an increasingly popular clinical tool as an alternative source of growth factors for several types of surgery, including oral bone regenerative procedures. PRP is a concentrated autologous source of several growth factors, particularly platelet-derived growth factor (PDGF) and transforming growth factor-␤ (i.e., TGF-␤ 1 and TGF-␤ 2 ), as well as vascular endothelial growth factor, insulin-like growth factor, and other growth factors possibly contained within platelets. Once the clinician prepares PRP by extracting a small amount of a patient's own blood, and then sequestering and concentrating the platelets, which is a process that requires 20 -30 minutes in an outpatient clinical setting, PRP can be used to enhance graft material to form a growth-factor rich membrane or to enhance a traditional membrane barrier. 3, 4 Its fibrinogen component also makes PRP an excellent hemostatic tool, tissue sealant, wound stabilizer, and graft condenser, through the creation of a gel-like substance that allows for sculpting and excellent adherence in defects.
Researchers have shown radiographically that adding PRP to graft material significantly accelerates the rate of bone formation and improves trabecular bone density as compared to sites treated with only autogenous graft material. 3, 5 Widespread clinical reports and recent published research also suggest that PRP significantly: enhances soft tissue healing; reduces bleeding, edema, and scarring; and decreases a patient's self-reported pain levels postoperatively. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Some evidence even suggests that adding PRP to graft material leads to bone growth that is more dense than native bone, a potential benefit that has not been reported in studies in which bone morphogenetic proteins or growth factors are applied singly. 5, 20 PRP growth factors are particularly attractive for cases in which conditions typically reduce the success of bone grafts and osseointegration. These include patients with an edentulous and severely atrophic maxilla, patients with osteoporosis, and those with prior dental disease, and subsequently scarred and altered tissues.
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The concentrated levels of PDGF and TGF-␤ in PRP, in addition to the presence of other possible growth factors or proteins in PRP, appear to provide benefits that lead to more rapid and effective bone regeneration. Scientific research focused specifically on PRP has been published in the dental literature thus far. The results have been promising and in agreement with preclinical and clinical trials showing enhanced bone regeneration when PDGF, TGF-␤, or other growth factors in various carriers are applied. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] Several studies have also shown benefits with autologous fibrin obtained from PRP with a concentration of PDGF and TGF-␤ contained in it. [35] [36] [37] [38] [39] [40] [41] [42] [43] These scientific data and several hundred clinical case reports since the late 1990s suggest that PRP may be useful in developing more dense bone earlier, a benefit that would allow earlier implant placement, earlier function, and higher predictability in compromised bone cases.
The most frequently cited controlled study on PRP to date included 88 patients undergoing bone augmentation with Ն5 cm mandibular continuity defects. 5 Two different investigators radiographically assessed the test sites treated with autogenous graft material plus PRP and the controls treated only with graft material. For each case, graft material was harvested from the patient's posterior ilium. At 2, 4, and 6 months, the investigators consistently rated the grafts with PRP as having reached maturity levels in nearly half the time as the normal rate. Histomorphometry also revealed graft bone densities in the PRP-treated group that were 15% to 30% higher than the controls at 6 months.
Several case study reports also indicate that PRP plus autograft or allograft materials improve regenerative results in severe bone defects. In one study, 5 patients presenting with severe localized periodontal bone defects, deep probing depths, severe bone loss, and guarded prognoses were treated with demineralized freeze-dried bone allografts plus PRP. 44 In each case, faster than usual bone formation was noted radiographically, with significant amounts observed as early as 2 months postoperatively, and on surgical reentry. New bone was of excellent quality, and probing depths were also significantly reduced within 4 to 6 months. A similar study showed that the local use of PRP in sinus grafting procedures facilitated the hard tissue mineralization rate of the grafted sinus. 45 Connective and gingival tissues also benefit from the growth factors in PRP, leading to enhanced tissue regeneration.
The posterior maxilla is clearly the most challenging area to restore, and PRP has shown promise for clinical sinus augmentation for implants as well. However, because of the large size of these defects, these cases appear to require PRP combined with graft materials that provide osteoinductive capabilities as well. For instance, one study reported achieving ineffective bone regeneration in sinus grafts using anorganic bovine bone plus PRP but effective results in the contralateral sinuses grafted with anorganic bovine bone plus osteogenic protein-1, also known as bone morphogenetic protein-7. 46 In addition, in histomorphometric assessments at 7-11 months following grafting and immediate implant placement, another study showed little difference in bone growth or implant contact between sinus grafts performed with anorganic bovine bone (Bio-Oss, Osteohealth, Shirley, NY) and membrane plus PRP over those performed without PRP. 47 However, another study showed excellent clinical results in sinus augmentation and large ridge defects grafted with PRP and PepGen P-15 (Dentsply, Lakewood, CO), a novel graft material that mimics both the inorganic and organic components of autogenous bone. 10 Reported in the study were the superb clinical appearance of healed ridges and presence of dense bone. Histologic assessment of bone cores in these cases revealed bone suitable for implant placement at 4 -6 months. There have been hundreds of successful maxillary sinus augmentations for immediate and delayed implant placement by clinicians using autogenous bone, with or without allogenic graft or PepGen P-15 as an extender, plus PRP.
Subjects and Materials
This study consisted of 20 patients who required sinus augmentation with a crestal bone height of approximately 7-9 mm in the posterior maxilla. All patients received a graft consisting of Cerasorb (Curasan, Kleinostheim, Germany), a beta tricalcium phosphate synthetic material, in one side (chosen randomly at the toss of a coin) and only autologous PRP in the contralateral side. 48 All sinus augmentations were performed with the simultaneous placement of dental implants.
MATERIALS AND METHODS
When the window is created on the side with PRP alone, the lateral wall must remain attached to the Schneiderian membrane when the membrane is elevated and, in this way, the wall serves as a "roof" to be supported by the simultaneously placed dental implants at the superior aspect. This process prevents or minimizes the membrane collapse from pressure in the maxillary sinus during breathing. Both sides of the sinus lift were treated with this same precautionary "roof" approach to minimize variables. Although this precaution is not critical in the contralateral side, which contains the graft material; on the grafted side, the lateral wall serves as the roof of the graft material.
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It was difficult, if not impossible, to leave the window attached to the Schneiderian membrane for the closed technique. Therefore, a piece of CollaTape (Integra LifeSciences Corp., Plainsboro, NJ) was placed after fracture of the sinus floor and elevation of the Schneiderian membrane to help tent the Schneiderian membrane before placement of the dental implants, and to minimize the collapse of the Schneiderian membrane (Fig. 1) . The membrane was soaked in the activated PRP and then inserted into the osteotomy. The membrane was elevated to its maximum extent. The Harvest Technologies (Plymouth, MA) gun applicator was used to spray and fill the entire sinus with PRP, including the canal in the residual crest. The self-tapping implant was then screwed in position per manufacturer's instructions. All implants used were Zimmer Dental (Carlsbad, CA) tapered screwvent implants, with a diameter of 3.7 mm and lengths ranging from 10 to 13 mm. For the open technique, a BioMend Extend (Zimmer Dental) membrane soaked in PRP was placed over the lateral window before closure of this soft tissue flap. Patients were given their dentures to wear immediately after the surgery.
RESULTS
At 6 months postoperatively, implants were exposed showing radiopaque evidence of mature bone in the apically grafted portion of the implants in each of the 20 patients (Fig.  2) . However, the difference noted was that the side with PRP alone was presumed to be all newly formed bone; whereas the contralateral side, which contained only graft material, continued to show radiopaque evidence of residual graft material. This result seems to indicate that a higher percentage of new bone formation occurs in the side where only PRP was used because no resorption of graft material is required. In conclusion, although a number of studies in recent years suggest ambiguous or indeterminate results regarding the ability of PRP to facilitate wound healing in alveolar bone regeneration procedures, 50-52 the use of PRP alone in appropriate sinuslift cases can produce bone growth and minimize the potential for residual graft material.
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